Home » Women's health » Celgene to give oral presentations on beta-thalassemia.

ACE-536: Beta-thalassemia Oral Presentation ACE-536: Myelodysplastic Syndromes Oral Presentation Sotatercept: Beta-thalassemia Oral Display ACE-536: Sickle Cell Disease Poster Presentation.. Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting Acceleron Pharma Inc. , a medical stage biopharmaceutical company focused on the discovery, development and commercialization of novel proteins therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 scientific trials will give three oral presentations of interim data from ongoing research in beta-thalassemia and myelodysplastic syndromes as well as a poster demonstration of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association in Milan, From June 12-15 Italy, 2014.The chance of death, medical center readmission or complications following surgery was forget about likely if the surgeon pulled a midnight shift before a daytime operation, the Canadian study showed. ‘I really believe what we are viewing in our study reflects self-regulation – – that surgeons strategy around their schedules predicated on their individual ability to tolerate rest deprivation,’ said senior study author Dr. Nancy Baxter, medical procedures division chief at St. Michael’s Medical center in Toronto. ‘Provided our findings, they appear to be doing a good job of it.’ The scholarly study was published online Aug. 26 in the New England Journal of Medicine. Baxter’s team viewed results for nearly 39,000 individuals undergoing one of 12 daytime surgeries, including gallbladder hysterectomy and removal.